BUSINESS● LOWAug 5 · Aug 5, 2026, 12:20 AM
Bio-Rad forecasts 2026 currency-neutral revenue growth of (-3%) to +0.5% while targeting $30M-$35M net cost savings by end of 2027
Seeking Alpha Tech
Bio-Rad forecasts its 2026 currency-neutral revenue growth and targets specific net cost savings by the end of 2027. This outlines the company's financial projections and efficiency goals.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowMines, telecoms, factories… Will African industrialists succeed in doing without diesel?Jeune AfriqueBUSINESS20m agoAlvotech wins FDA nod for new manufacturing process for Humira biosimilarSeeking Alpha Tech